Dawaa Reference

chronic

Congenital digestive system anomaly

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Hirschsprung Disease - StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK562142/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class DD55 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

Structural anomalies (e.g. biliary atresia, Hirschsprung's disease, congenital megacolon, esophageal atresia) present in infancy with feeding difficulty, jaundice, or failure to pass stool; management is pediatric surgical, not something a GP prescribes for. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Structural anomalies (e.g. biliary atresia, Hirschsprung's disease, congenital megacolon, esophageal atresia) present in infancy with feeding difficulty, jaundice, or failure to pass stool; management is pediatric surgical, not something a GP prescribes for.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Failure to pass meconium within 48 hours, bilious vomiting in a neonate, progressive abdominal distension, or persistent neonatal jaundice with pale stools and dark urine (time-critical for biliary atresia): refer urgently.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.